UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 106

Sortiert nach

Loss of the preferential control over the striato-nigral direct pathway by striatal NMDA receptors in a rat model of Parkinson's disease

Analyst (London), 2015-06, Vol.14 (11), p.383-3839

2015

Link zum Volltext

Verfügbarkeit prüfen

Influence of the frequency parameter on extracellular glutamate and γ-aminobutyric acid in substantia nigra and globus pallidus during electrical stimulation of subthalamic nucleus in rats

Journal of neuroscience research, 2003-04, Vol.72 (2), p.259-267

2003

Link zum Volltext

Verfügbarkeit prüfen

Voltage-operated Ca2+ channels regulate dopamine release from somata of dopamine neurons in the substantia nigra pars compacta

Biochemical and biophysical research communications, 2008-09, Vol.373 (4), p.665-669

2008

Link zum Volltext

Verfügbarkeit prüfen

Locomotor activity and evoked dopamine release are reduced in mice overexpressing A30P-mutated human α-synuclein

Neurobiology of disease, 2005-11, Vol.20 (2), p.303-313

2005

Link zum Volltext

Verfügbarkeit prüfen

Neurturin Effects on Nigrostriatal Dopamine Release and Content: Comparison with GDNF

Neurochemical research, 2010-05, Vol.35 (5), p.727-734

2010

Link zum Volltext

Verfügbarkeit prüfen

Adenosine A(2A) receptor-mediated modulation of GABA and glutamate release in the output regions of the basal ganglia in a rodent model of Parkinson's disease

Neuroscience, 2004, Vol.127 (1), p.223

2004

Link zum Volltext

Verfügbarkeit prüfen

Effects of noradrenergic lesions on MPTP/MPP+ kinetics and MPTP-induced nigrostriatal dopamine depletions

The Journal of pharmacology and experimental therapeutics, 1997-10, Vol.283 (1), p.100

1997

Link zum Volltext

Verfügbarkeit prüfen

Prenatal cocaine exposure decreases nigrostriatal dopamine release in vitro: Effects of age and sex

Synapse (New York, N.Y.), 2004-08, Vol.53 (2), p.74-89

2004

Link zum Volltext

Verfügbarkeit prüfen

L-DOPA-induced modulation of GABA and glutamate release in substantia nigra pars reticulata in a rodent model of Parkinson's disease

Synapse (New York, N.Y.), 2004-05, Vol.52 (2), p.163-165

2004

Link zum Volltext

Verfügbarkeit prüfen

Modulation of neurotransmitter release in the basal ganglia of the rat brain by dynorphin peptides

The Journal of pharmacology and experimental therapeutics, 1999-09, Vol.290 (3), p.1307

1999

Link zum Volltext

Verfügbarkeit prüfen

alpha2-Adrenoceptor-mediated modulation of the release of GABA and noradrenaline in the rat substantia nigra pars reticulata

Neuroscience letters, 2006-03, Vol.395 (2), p.138-142

2006

Link zum Volltext

Verfügbarkeit prüfen

5-HT(1B) receptor regulation of serotonin (5-HT) release by endogenous 5-HT in the substantia nigra

Neuroscience, 2010-01, Vol.165 (1), p.212-220

2010

Link zum Volltext

Verfügbarkeit prüfen

Ultrastructural evidence for dendritic release of acetylcholinesterase in the rat substantia nigra

Folia histochemica et cytobiologica, 1999, Vol.37 (4), p.243

1999

Link zum Volltext

Verfügbarkeit prüfen

Effect of superficial radial nerve stimulation on the activity of nigro-striatal dopaminergic neurons in the cat: role of cutaneous sensory input

Journal of Neural Transmission, 1982-01, Vol.53 (2-3), p.133-146

1982

Link zum Volltext

Verfügbarkeit prüfen

Amphetamine-induced and spontaneous release of dopamine from A9 and A10 cell dendrites: an in vitro electrophysiological study in the mouse

Journal of neural transmission. General section, 1991, Vol.84 (3), p.183

1991

Link zum Volltext

Verfügbarkeit prüfen

Disposition and role of newly synthesized amines in central catecholaminergic neurons

Advances in biochemical psychopharmacology, 1972, Vol.6, p.93

1972

Link zum Volltext

Verfügbarkeit prüfen

In vivo evidence for a dendritic release of dopamine in the cat substantia nigra

Applied neurophysiology, 1979, Vol.42 (1-2), p.57

1979

Link zum Volltext

Verfügbarkeit prüfen

A Cortical Pathogenic Theory of Parkinson’s Disease

Neuron (Cambridge, Mass.), 2018-09, Vol.99 (6), p.1116-1128

2018

Link zum Volltext

Verfügbarkeit prüfen

Rosmarinic acid suppresses Alzheimer's disease development by reducing amyloid β aggregation by increasing monoamine secretion

Scientific reports, 2019-06, Vol.9 (1), p.8711-13, Article 8711

2019

Link zum Volltext

Verfügbarkeit prüfen

The monoacylglycerol lipase inhibitor JZL184 is neuroprotective and alters glial cell phenotype in the chronic MPTP mouse model

Neurobiology of aging, 2014-11, Vol.35 (11), p.2603-2616

2014

Link zum Volltext

Verfügbarkeit prüfen

Investigation of Long Non-coding RNA Expression Profiles in the Substantia Nigra of Parkinson’s Disease

Cellular and molecular neurobiology, 2017-03, Vol.37 (2), p.329-338

2017

Link zum Volltext

Verfügbarkeit prüfen

l -DOPA-induced dyskinesia in hemiparkinsonian rats is associated with up-regulation of adenylyl cyclase type V/VI and increased GABA release in the substantia nigra reticulata

Neurobiology of disease, 2011-01, Vol.41 (1), p.51-61

2011

Link zum Volltext

Verfügbarkeit prüfen

Phosphodiesterase 10A controls D1-mediated facilitation of GABA release from striato-nigral projections under normal and dopamine-depleted conditions

Neuropharmacology, 2014-01, Vol.76, p.127-136

2014

Link zum Volltext

Verfügbarkeit prüfen

P7C3 inhibits GSK3β activation to protect dopaminergic neurons against neurotoxin-induced cell death in vitro and in vivo

Cell death & disease, 2017-06, Vol.8 (6), p.e2858-e2858

2017

Link zum Volltext

Verfügbarkeit prüfen

Dopamine promotes formation and secretion of non-fibrillar alpha-synuclein oligomers

Experimental and Molecular Medicine, 2011, 43(4), , pp.216-222

2011

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 106

Suche als RSS-Feed

Aktive Filter

ThemaBiological And Medical Sciences

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(95)
Mit Volltextzugriff
(80)

Publikationsform

Artikel
(106)

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Loss of the preferential control over the striato-nigral direct pathway by striatal NMDA receptors in a rat model of Parkinson's disease

Influence of the frequency parameter on extracellular glutamate and γ-aminobutyric acid in substantia nigra and globus pallidus during electrical stimulation of subthalamic nucleus in rats

Voltage-operated Ca2+ channels regulate dopamine release from somata of dopamine neurons in the substantia nigra pars compacta

Locomotor activity and evoked dopamine release are reduced in mice overexpressing A30P-mutated human α-synuclein

Neurturin Effects on Nigrostriatal Dopamine Release and Content: Comparison with GDNF

Adenosine A(2A) receptor-mediated modulation of GABA and glutamate release in the output regions of the basal ganglia in a rodent model of Parkinson's disease

Effects of noradrenergic lesions on MPTP/MPP+ kinetics and MPTP-induced nigrostriatal dopamine depletions

Prenatal cocaine exposure decreases nigrostriatal dopamine release in vitro: Effects of age and sex

L-DOPA-induced modulation of GABA and glutamate release in substantia nigra pars reticulata in a rodent model of Parkinson's disease

Modulation of neurotransmitter release in the basal ganglia of the rat brain by dynorphin peptides

alpha2-Adrenoceptor-mediated modulation of the release of GABA and noradrenaline in the rat substantia nigra pars reticulata

5-HT(1B) receptor regulation of serotonin (5-HT) release by endogenous 5-HT in the substantia nigra

Ultrastructural evidence for dendritic release of acetylcholinesterase in the rat substantia nigra

Effect of superficial radial nerve stimulation on the activity of nigro-striatal dopaminergic neurons in the cat: role of cutaneous sensory input

Amphetamine-induced and spontaneous release of dopamine from A9 and A10 cell dendrites: an in vitro electrophysiological study in the mouse

Disposition and role of newly synthesized amines in central catecholaminergic neurons

In vivo evidence for a dendritic release of dopamine in the cat substantia nigra

A Cortical Pathogenic Theory of Parkinson’s Disease

Rosmarinic acid suppresses Alzheimer's disease development by reducing amyloid β aggregation by increasing monoamine secretion

The monoacylglycerol lipase inhibitor JZL184 is neuroprotective and alters glial cell phenotype in the chronic MPTP mouse model

Investigation of Long Non-coding RNA Expression Profiles in the Substantia Nigra of Parkinson’s Disease

l -DOPA-induced dyskinesia in hemiparkinsonian rats is associated with up-regulation of adenylyl cyclase type V/VI and increased GABA release in the substantia nigra reticulata

Phosphodiesterase 10A controls D1-mediated facilitation of GABA release from striato-nigral projections under normal and dopamine-depleted conditions

P7C3 inhibits GSK3β activation to protect dopaminergic neurons against neurotoxin-induced cell death in vitro and in vivo

Dopamine promotes formation and secretion of non-fibrillar alpha-synuclein oligomers

Aktive Filter

Suchergebnisse filtern